Abstract:Objective: To examine the effects of extended-released methylphenidate(Concerta) on clinical improvements and different dimensions(experimental psychological and ecological) inhibition of children with attention deficit hyperactivity disorder(ADHD),and to evaluate the correlation between the improvement of ADHD symptoms and that of different dimensions inhibition.Methods: In this self-control study,28 children with ADHD [aged(10.8±1.8) years] were treated with extended-released methylphenidate(18～54mg/d)for 4~6 weeks.ADHD symptoms,including experimental psychological inhibition and ecological inhibition,were assessed with the parent form ADHD-Ⅳ rating scale,Go/No Go task and inhibition subscale of BRIEF before and after the treatment respectively.Results: The scores of the parent form ADHD-Ⅳ rating scale [(32.8±9.2) vs.(20.7±11.9)],inattentive subscale [(18.6±4.1) vs.(11.5±6.1)],hyperactive/impulsive subscale [(14.2±6.6) vs.(9.1±6.6)],inhibition subscale of BRIEF [(1.96±0.52) vs.(1.73±0.43)] and the commission numbers of Go/No go task [(22.0±10.9) vs.(14.8±10.4)] were significantly decreased after the treatment with extended-released methylphenidate(Ps0.05).The reduction rate of the inattentive subscales had positive correlation with that of the commission numbers in the Go/No go task(r=0.415,P0.05),and the reduction rate of the hyperactive/impulsive subscales had positive correlation with that of the inhibition subscale of BRIEF(r=0.500,P0.01).Conclusion:The extended-released methylphenidate not only has significant clinical effects,but also can improve the experimental psychological and ecological inhibition for the children with ADHD.The BRIEF scale has good etiological validities for evaluating the executive functions for ADHD,and the experimental psychological tests are the necessary compensations for executive functions evaluation in clinical practices.

Effects of Extended-released Methylphenidate on the Inhibition of Children with Attention Deficit Hyperactivity Disorder